| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 9.89e-47 | 46 | 53 | 22 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 2.70e-31 | 188 | 53 | 22 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.88e-16 | 891 | 53 | 22 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 4.49e-04 | 12 | 53 | 2 | GO:0048407 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 | 4.07e-20 | 377 | 53 | 19 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 | 4.28e-20 | 378 | 53 | 19 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 | 4.50e-20 | 379 | 53 | 19 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 7.21e-11 | 12 | 53 | 5 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 7.71e-10 | 18 | 53 | 5 | GO:0038065 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.49e-06 | 76 | 53 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 1.71e-04 | 42 | 53 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.97e-04 | 44 | 53 | 3 | GO:0045023 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 WDR33 COL5A3 COL14A1 COL22A1 COL25A1 | 1.67e-41 | 88 | 55 | 23 | GO:0005581 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.06e-25 | 332 | 55 | 22 | GO:0005788 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL7A1 COL10A1 COL11A2 COL5A3 | 4.97e-24 | 21 | 55 | 11 | GO:0098644 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 3.01e-21 | 530 | 55 | 22 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 CCN5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.32e-20 | 656 | 55 | 23 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 CCN5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.41e-20 | 658 | 55 | 23 | GO:0030312 |
| GeneOntologyCellularComponent | network-forming collagen trimer | 6.98e-15 | 8 | 55 | 6 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 6.98e-15 | 8 | 55 | 6 | GO:0098645 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 6.27e-13 | 6 | 55 | 5 | GO:0005593 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 6.27e-13 | 6 | 55 | 5 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.82e-12 | 8 | 55 | 5 | GO:0098651 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 4.29e-11 | 4 | 55 | 4 | GO:0005594 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.09e-08 | 12 | 55 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.09e-08 | 12 | 55 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | 3.12e-08 | 122 | 55 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.72e-07 | 5 | 55 | 3 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL10A1 COL11A2 KCNN2 COL5A3 KIFC2 | 9.28e-06 | 1187 | 55 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | anchoring collagen complex | 2.04e-05 | 3 | 55 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | collagen type V trimer | 4.06e-05 | 4 | 55 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 6.65e-05 | 30 | 55 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.19e-04 | 96 | 55 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | bBAF complex | 3.02e-04 | 10 | 55 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | ATPase complex | 3.70e-04 | 129 | 55 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | npBAF complex | 6.06e-04 | 14 | 55 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 6.06e-04 | 14 | 55 | 2 | GO:0072379 | |
| GeneOntologyCellularComponent | brahma complex | 6.06e-04 | 14 | 55 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 7.97e-04 | 16 | 55 | 2 | GO:0071565 | |
| HumanPheno | Myopia | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL9A1 COL9A2 COL9A3 ARID1B COL11A2 PNPLA6 BICRA SMARCC2 GTF2IRD1 | 2.98e-08 | 447 | 29 | 14 | HP:0000545 |
| HumanPheno | Vitreoretinopathy | 1.03e-07 | 22 | 29 | 5 | HP:0007773 | |
| HumanPheno | Arthralgia of the hip | 1.05e-07 | 9 | 29 | 4 | HP:0003365 | |
| HumanPheno | Fragmentation of the metacarpal epiphyses | 1.66e-07 | 3 | 29 | 3 | HP:0009189 | |
| HumanPheno | Fragmented epiphyses of the upper limbs | 1.66e-07 | 3 | 29 | 3 | HP:0003841 | |
| HumanPheno | Radially deviated wrists | 1.66e-07 | 3 | 29 | 3 | HP:0006190 | |
| HumanPheno | Abnormality of the epiphyses of the elbow | 1.66e-07 | 3 | 29 | 3 | HP:0003946 | |
| HumanPheno | Abnormal forearm morphology | COL2A1 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B BICRA GTF2IRD1 | 3.91e-07 | 239 | 29 | 10 | HP:0002973 |
| HumanPheno | Epiphyseal dysplasia | 4.50e-07 | 29 | 29 | 5 | HP:0002656 | |
| HumanPheno | Irregular vertebral endplates | 5.38e-07 | 30 | 29 | 5 | HP:0003301 | |
| HumanPheno | Ulnar deviated club hands | 6.61e-07 | 4 | 29 | 3 | HP:0006055 | |
| HumanPheno | Reduced arm span | 6.61e-07 | 4 | 29 | 3 | HP:0012770 | |
| HumanPheno | Osteoarthritis | 1.29e-06 | 65 | 29 | 6 | HP:0002758 | |
| HumanPheno | Abnormality of refraction | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL9A1 COL9A2 COL9A3 ARID1B COL11A2 PNPLA6 BICRA SMARCC2 COL25A1 GTF2IRD1 | 1.43e-06 | 709 | 29 | 15 | HP:0000539 |
| HumanPheno | Fragmented epiphyses | 1.65e-06 | 5 | 29 | 3 | HP:0100168 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.65e-06 | 5 | 29 | 3 | HP:0007964 | |
| HumanPheno | Abnormal patella morphology | 1.79e-06 | 109 | 29 | 7 | HP:0003045 | |
| HumanPheno | Abnormality of the vertebral endplates | 1.83e-06 | 38 | 29 | 5 | HP:0005106 | |
| HumanPheno | Abnormal morphology of the radius | COL2A1 COL5A2 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B BICRA GTF2IRD1 | 1.86e-06 | 217 | 29 | 9 | HP:0002818 |
| HumanPheno | Knee pain | 1.92e-06 | 17 | 29 | 4 | HP:0030839 | |
| HumanPheno | Amblyopia | 2.15e-06 | 112 | 29 | 7 | HP:0000646 | |
| HumanPheno | Abnormality of the joints of the lower limbs | COL2A1 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B SALL1 PNPLA6 COL25A1 GTF2IRD1 | 2.93e-06 | 547 | 29 | 13 | HP:0100239 |
| HumanPheno | Abnormality of radial epiphyses | 3.28e-06 | 6 | 29 | 3 | HP:0003999 | |
| HumanPheno | Abnormal forearm bone morphology | COL2A1 COL5A2 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B BICRA GTF2IRD1 | 3.75e-06 | 236 | 29 | 9 | HP:0040072 |
| HumanPheno | Abnormal metacarpal epiphysis morphology | 4.74e-06 | 21 | 29 | 4 | HP:0005913 | |
| HumanPheno | Abnormality of the epiphyses of the feet | 5.72e-06 | 7 | 29 | 3 | HP:0010631 | |
| HumanPheno | Abnormality of the knee | COL2A1 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B PNPLA6 COL25A1 GTF2IRD1 | 6.32e-06 | 491 | 29 | 12 | HP:0002815 |
| HumanPheno | Abnormal vitreous humor morphology | 6.67e-06 | 49 | 29 | 5 | HP:0004327 | |
| HumanPheno | Small epiphyses | 8.32e-06 | 24 | 29 | 4 | HP:0010585 | |
| HumanPheno | Abnormal limb epiphysis morphology | 8.72e-06 | 138 | 29 | 7 | HP:0006505 | |
| HumanPheno | Cataract | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL7A1 COL9A1 COL9A2 COL9A3 COL11A2 SALL1 PNPLA6 PITX3 COL25A1 GTF2IRD1 | 9.62e-06 | 822 | 29 | 15 | HP:0000518 |
| HumanPheno | Irregular epiphyses | 9.87e-06 | 25 | 29 | 4 | HP:0010582 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.13e-05 | 94 | 29 | 6 | HP:0006500 | |
| HumanPheno | High myopia | 1.13e-05 | 94 | 29 | 6 | HP:0011003 | |
| HumanPheno | Abnormal lens morphology | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL7A1 COL9A1 COL9A2 COL9A3 COL11A2 SALL1 PNPLA6 PITX3 COL25A1 GTF2IRD1 | 1.21e-05 | 837 | 29 | 15 | HP:0000517 |
| HumanPheno | Limb pain | 1.42e-05 | 57 | 29 | 5 | HP:0009763 | |
| HumanPheno | Abnormality of the elbow | COL2A1 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 ARID1B COL25A1 | 1.61e-05 | 282 | 29 | 9 | HP:0009811 |
| HumanPheno | Abnormal hand epiphysis morphology | 1.68e-05 | 59 | 29 | 5 | HP:0005924 | |
| HumanPheno | Abnormal knee morphology | COL2A1 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B COL25A1 GTF2IRD1 | 1.80e-05 | 364 | 29 | 10 | HP:0034669 |
| HumanPheno | Lenticonus | 1.94e-05 | 10 | 29 | 3 | HP:0001142 | |
| HumanPheno | Genu varum | 1.99e-05 | 61 | 29 | 5 | HP:0002970 | |
| HumanPheno | Abnormal upper limb epiphysis morphology | 2.52e-05 | 64 | 29 | 5 | HP:0003839 | |
| HumanPheno | Abnormal arm span | 2.66e-05 | 11 | 29 | 3 | HP:0012769 | |
| HumanPheno | Schmorl's node | 3.13e-05 | 2 | 29 | 2 | HP:0030041 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 3.13e-05 | 2 | 29 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 3.13e-05 | 2 | 29 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 3.13e-05 | 2 | 29 | 2 | HP:0006756 | |
| HumanPheno | Internal tibial torsion | 3.13e-05 | 2 | 29 | 2 | HP:0034372 | |
| HumanPheno | Abnormality of lower limb joint | COL2A1 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B KMT2D COL11A2 SALL1 PNPLA6 BICRA COL25A1 GTF2IRD1 | 3.14e-05 | 1027 | 29 | 16 | HP:0100491 |
| HumanPheno | Coxa vara | 3.38e-05 | 68 | 29 | 5 | HP:0002812 | |
| HumanPheno | Radial deviation of the hand | 3.53e-05 | 12 | 29 | 3 | HP:0009486 | |
| HumanPheno | Abnormal upper limb bone morphology | COL2A1 COL5A2 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B COL11A2 SALL1 BICRA GTF2IRD1 | 3.60e-05 | 484 | 29 | 11 | HP:0040070 |
| HumanPheno | Retinal detachment | 4.18e-05 | 118 | 29 | 6 | HP:0000541 | |
| HumanPheno | Bilateral coxa valga | 4.57e-05 | 13 | 29 | 3 | HP:0010665 | |
| HumanPheno | Small nail | 5.49e-05 | 183 | 29 | 7 | HP:0001792 | |
| HumanPheno | Platyspondyly | 5.53e-05 | 124 | 29 | 6 | HP:0000926 | |
| HumanPheno | Postexertional symptom exacerbation | 5.79e-05 | 14 | 29 | 3 | HP:0030973 | |
| HumanPheno | Sensorineural hearing impairment | COL2A1 COL4A3 COL4A5 COL4A6 COL9A1 COL9A2 COL9A3 ARID1B KMT2D COL11A2 SALL1 PNPLA6 BICRA COL25A1 GTF2IRD1 | 6.44e-05 | 958 | 29 | 15 | HP:0000407 |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL2A1 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B KMT2D COL11A2 BICRA COL25A1 GTF2IRD1 | 7.12e-05 | 730 | 29 | 13 | HP:0002644 |
| HumanPheno | Enlarged epiphyses | 7.21e-05 | 15 | 29 | 3 | HP:0010580 | |
| HumanPheno | Waddling gait | 7.22e-05 | 130 | 29 | 6 | HP:0002515 | |
| HumanPheno | Lower limb pain | 7.42e-05 | 41 | 29 | 4 | HP:0012514 | |
| HumanPheno | Abnormality of the ankle | 7.46e-05 | 192 | 29 | 7 | HP:0003028 | |
| HumanPheno | Abnormal cornea morphology | COL4A1 COL4A5 COL4A6 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 ARID1B KMT2D SALL1 PITX3 GTF2IRD1 | 8.71e-05 | 744 | 29 | 13 | HP:0000481 |
| HumanPheno | Glomerular basement membrane lamellation | 9.36e-05 | 3 | 29 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 9.36e-05 | 3 | 29 | 2 | HP:0011501 | |
| HumanPheno | Vulvar neoplasm | 9.36e-05 | 3 | 29 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 9.36e-05 | 3 | 29 | 2 | HP:0032141 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | COL2A1 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B KMT2D COL11A2 BICRA SMARCC2 COL25A1 | 9.63e-05 | 538 | 29 | 11 | HP:0005927 |
| HumanPheno | Abnormal femoral neck/head morphology | 9.98e-05 | 201 | 29 | 7 | HP:0003366 | |
| HumanPheno | Prominent eyelashes | 1.07e-04 | 17 | 29 | 3 | HP:0011231 | |
| HumanPheno | Abnormal hip bone morphology | COL2A1 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B KMT2D COL11A2 BICRA COL25A1 | 1.15e-04 | 653 | 29 | 12 | HP:0003272 |
| HumanPheno | Abnormality of lens shape | 1.28e-04 | 18 | 29 | 3 | HP:0011526 | |
| HumanPheno | Joint hypermobility | COL2A1 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 ARID1B KMT2D BICRA SMARCC2 GTF2IRD1 | 1.32e-04 | 557 | 29 | 11 | HP:0001382 |
| HumanPheno | Coxa valga | 1.45e-04 | 92 | 29 | 5 | HP:0002673 | |
| HumanPheno | Abnormal anterior eye segment morphology | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 ARID1B KMT2D COL11A2 SALL1 PNPLA6 PITX3 COL25A1 GTF2IRD1 | 1.61e-04 | 1450 | 29 | 18 | HP:0004328 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | COL2A1 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B KMT2D COL11A2 BICRA SMARCC2 COL25A1 | 1.69e-04 | 572 | 29 | 11 | HP:0006496 |
| HumanPheno | Aspiration pneumonia | 1.69e-04 | 95 | 29 | 5 | HP:0011951 | |
| HumanPheno | Glomerular deposits | 1.77e-04 | 20 | 29 | 3 | HP:0030949 | |
| HumanPheno | Metaphyseal cupping | 1.77e-04 | 20 | 29 | 3 | HP:0003021 | |
| HumanPheno | Proportionate short stature | 1.78e-04 | 153 | 29 | 6 | HP:0003508 | |
| HumanPheno | short, dumbbell appearance of long bones | 1.86e-04 | 4 | 29 | 2 | HP:0005061 | |
| HumanPheno | Dumbbell-shaped femur | 1.86e-04 | 4 | 29 | 2 | HP:0006375 | |
| HumanPheno | Pretibial blistering | 1.86e-04 | 4 | 29 | 2 | HP:0012221 | |
| HumanPheno | Short tubular bones of the hand | 1.86e-04 | 4 | 29 | 2 | HP:0001248 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 1.86e-04 | 4 | 29 | 2 | HP:0010590 | |
| HumanPheno | Mild short stature | 2.06e-04 | 21 | 29 | 3 | HP:0003502 | |
| HumanPheno | Abnormal femoral neck morphology | 2.28e-04 | 160 | 29 | 6 | HP:0003367 | |
| HumanPheno | Abnormality of upper limb joint | COL2A1 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 ARID1B COL11A2 BICRA COL25A1 GTF2IRD1 | 2.44e-04 | 705 | 29 | 12 | HP:0009810 |
| HumanPheno | Functional abnormality of the inner ear | COL2A1 COL4A3 COL4A5 COL4A6 COL9A1 COL9A2 COL9A3 ARID1B KMT2D COL11A2 SALL1 PNPLA6 BICRA COL25A1 GTF2IRD1 | 2.60e-04 | 1077 | 29 | 15 | HP:0011389 |
| HumanPheno | Genu valgum | 2.70e-04 | 165 | 29 | 6 | HP:0002857 | |
| HumanPheno | Tibial torsion | 2.72e-04 | 23 | 29 | 3 | HP:0100694 | |
| HumanPheno | Bowing of the long bones | 2.73e-04 | 316 | 29 | 8 | HP:0006487 | |
| HumanPheno | Abnormal hand morphology | COL2A1 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 ARID1B KMT2D COL11A2 SALL1 PNPLA6 BICRA SMARCC2 COL25A1 GTF2IRD1 | 2.75e-04 | 1082 | 29 | 15 | HP:0005922 |
| HumanPheno | Flat face | 2.83e-04 | 106 | 29 | 5 | HP:0012368 | |
| HumanPheno | Abnormal tibia morphology | 2.96e-04 | 107 | 29 | 5 | HP:0002992 | |
| HumanPheno | Malar flattening | 3.02e-04 | 240 | 29 | 7 | HP:0000272 | |
| HumanPheno | Overfolding of the superior helices | 3.10e-04 | 5 | 29 | 2 | HP:0004453 | |
| HumanPheno | Hypoplasia of the capital femoral epiphysis | 3.10e-04 | 24 | 29 | 3 | HP:0003090 | |
| HumanPheno | Aplasia/Hypoplasia of the capital femoral epiphysis | 3.10e-04 | 24 | 29 | 3 | HP:0005003 | |
| MousePheno | abnormal articular cartilage morphology | 1.26e-05 | 14 | 47 | 3 | MP:0006433 | |
| MousePheno | hearing/vestibular/ear phenotype | COL2A1 COL4A2 COL4A3 CCN5 COL9A1 COL9A2 COL9A3 KMT2D COL11A2 SALL1 PLA2G3 SMARCC2 | 3.19e-05 | 905 | 47 | 12 | MP:0005377 |
| MousePheno | hematuria | 3.32e-05 | 19 | 47 | 3 | MP:0005161 | |
| MousePheno | hemorrhage | COL2A1 COL4A1 PTOV1 COL4A2 COL4A3 ZHX3 PNPLA6 SZT2 BICRA GTF2IRD1 | 5.73e-05 | 664 | 47 | 10 | MP:0001914 |
| MousePheno | buphthalmos | 6.61e-05 | 4 | 47 | 2 | MP:0009274 | |
| MousePheno | abnormal ear physiology | COL2A1 COL4A3 CCN5 COL9A1 COL9A2 COL9A3 COL11A2 SALL1 PLA2G3 SMARCC2 | 7.35e-05 | 684 | 47 | 10 | MP:0003878 |
| MousePheno | abnormal body length | 7.57e-05 | 550 | 47 | 9 | MP:0001256 | |
| MousePheno | abnormal blood circulation | COL2A1 COL4A1 PTOV1 COL4A2 COL4A3 ZHX3 COL11A2 PNPLA6 SZT2 BICRA GTF2IRD1 | 8.62e-05 | 845 | 47 | 11 | MP:0002128 |
| MousePheno | anterior polar cataract | 1.10e-04 | 5 | 47 | 2 | MP:0010259 | |
| MousePheno | polar cataract | 1.65e-04 | 6 | 47 | 2 | MP:0010258 | |
| MousePheno | decreased body length | 1.87e-04 | 484 | 47 | 8 | MP:0001258 | |
| MousePheno | abnormal hearing physiology | COL2A1 COL4A3 CCN5 COL9A1 COL9A2 COL9A3 COL11A2 SALL1 SMARCC2 | 2.47e-04 | 643 | 47 | 9 | MP:0001963 |
| MousePheno | podocyte foot process effacement | 2.77e-04 | 38 | 47 | 3 | MP:0008140 | |
| MousePheno | macrophthalmia | 3.06e-04 | 8 | 47 | 2 | MP:0001296 | |
| MousePheno | enlarged tectorial membrane | 3.06e-04 | 8 | 47 | 2 | MP:0004591 | |
| MousePheno | prominent forehead | 3.06e-04 | 8 | 47 | 2 | MP:0030049 | |
| MousePheno | dilated renal tubule | 3.61e-04 | 101 | 47 | 4 | MP:0002705 | |
| MousePheno | dilated glomerular capillary | 3.92e-04 | 9 | 47 | 2 | MP:0011509 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 4.28e-04 | 44 | 47 | 3 | MP:0011348 | |
| MousePheno | abnormal hyaline cartilage morphology | 4.89e-04 | 46 | 47 | 3 | MP:0006429 | |
| MousePheno | abnormal glomerular capillary morphology | 5.21e-04 | 47 | 47 | 3 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 5.54e-04 | 48 | 47 | 3 | MP:0011310 | |
| MousePheno | abnormal auditory brainstem response | 6.01e-04 | 576 | 47 | 8 | MP:0004738 | |
| MousePheno | abnormal hearing electrophysiology | 7.35e-04 | 594 | 47 | 8 | MP:0006335 | |
| MousePheno | kidney atrophy | 7.42e-04 | 53 | 47 | 3 | MP:0004970 | |
| MousePheno | abnormal synovial joint morphology | 7.83e-04 | 124 | 47 | 4 | MP:0030804 | |
| MousePheno | abnormal podocyte foot process morphology | 8.27e-04 | 55 | 47 | 3 | MP:0008059 | |
| MousePheno | dilated capillary | 8.43e-04 | 13 | 47 | 2 | MP:0020326 | |
| MousePheno | abnormal ureteric bud elongation | 8.43e-04 | 13 | 47 | 2 | MP:0010982 | |
| MousePheno | total cataract | 8.43e-04 | 13 | 47 | 2 | MP:0010263 | |
| MousePheno | impaired hearing | 8.78e-04 | 223 | 47 | 5 | MP:0006325 | |
| MousePheno | abnormal renal tubule morphology | 9.51e-04 | 227 | 47 | 5 | MP:0002703 | |
| MousePheno | kidney hemorrhage | 9.81e-04 | 14 | 47 | 2 | MP:0000533 | |
| Domain | Collagen | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 WDR33 COL5A3 COL14A1 COL22A1 COL25A1 | 5.14e-41 | 85 | 54 | 23 | PF01391 |
| Domain | Collagen | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 WDR33 COL5A3 COL14A1 COL22A1 COL25A1 | 5.14e-41 | 85 | 54 | 23 | IPR008160 |
| Domain | TSPN | COL24A1 COL9A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 | 5.54e-18 | 23 | 54 | 9 | SM00210 |
| Domain | Laminin_G | COL24A1 COL9A1 COL11A2 COL16A1 COL19A1 CELSR2 COL21A1 COL5A3 COL14A1 COL22A1 | 7.93e-16 | 58 | 54 | 10 | IPR001791 |
| Domain | C4 | 1.00e-12 | 6 | 54 | 5 | SM00111 | |
| Domain | - | 1.00e-12 | 6 | 54 | 5 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.00e-12 | 6 | 54 | 5 | IPR001442 | |
| Domain | NC1_IV | 1.00e-12 | 6 | 54 | 5 | PS51403 | |
| Domain | C4 | 1.00e-12 | 6 | 54 | 5 | PF01413 | |
| Domain | NC1_FIB | 7.62e-11 | 11 | 54 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 7.62e-11 | 11 | 54 | 5 | IPR000885 | |
| Domain | Fib_collagen_C | 7.62e-11 | 11 | 54 | 5 | PD002078 | |
| Domain | COLFI | 7.62e-11 | 11 | 54 | 5 | SM00038 | |
| Domain | COLFI | 7.62e-11 | 11 | 54 | 5 | PF01410 | |
| Domain | - | COL24A1 COL9A1 COL11A2 COL16A1 COL19A1 CELSR2 COL21A1 COL5A3 | 2.85e-10 | 95 | 54 | 8 | 2.60.120.200 |
| Domain | ConA-like_dom | COL24A1 COL9A1 COL11A2 COL16A1 COL19A1 CELSR2 COL21A1 COL5A3 COL14A1 COL22A1 | 6.10e-10 | 219 | 54 | 10 | IPR013320 |
| Domain | VWA | 5.71e-07 | 56 | 54 | 5 | PF00092 | |
| Domain | - | 2.31e-06 | 74 | 54 | 5 | 3.40.50.410 | |
| Domain | VWFA | 3.85e-06 | 82 | 54 | 5 | PS50234 | |
| Domain | VWA | 4.34e-06 | 84 | 54 | 5 | SM00327 | |
| Domain | Laminin_G_2 | 5.28e-06 | 40 | 54 | 4 | PF02210 | |
| Domain | VWF_A | 9.73e-06 | 99 | 54 | 5 | IPR002035 | |
| Domain | CTDL_fold | 1.42e-05 | 107 | 54 | 5 | IPR016187 | |
| Domain | VWC | 7.11e-05 | 28 | 54 | 3 | PF00093 | |
| Domain | VWFC_1 | 1.52e-04 | 36 | 54 | 3 | PS01208 | |
| Domain | VWC | 1.79e-04 | 38 | 54 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.79e-04 | 38 | 54 | 3 | PS50184 | |
| Domain | VWF_dom | 2.42e-04 | 42 | 54 | 3 | IPR001007 | |
| Domain | LamG | 2.78e-04 | 44 | 54 | 3 | SM00282 | |
| Domain | - | 1.22e-03 | 18 | 54 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 1.22e-03 | 18 | 54 | 2 | IPR020901 | |
| Domain | BPTI_KUNITZ_2 | 1.36e-03 | 19 | 54 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.36e-03 | 19 | 54 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.36e-03 | 19 | 54 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 2.00e-03 | 23 | 54 | 2 | IPR002223 | |
| Domain | TNFR | 2.55e-03 | 26 | 54 | 2 | SM00208 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 4.09e-03 | 33 | 54 | 2 | IPR001368 | |
| Domain | LAM_G_DOMAIN | 5.40e-03 | 38 | 54 | 2 | PS50025 | |
| Domain | - | 9.01e-03 | 283 | 54 | 4 | 1.10.10.60 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.80e-45 | 44 | 47 | 22 | M27812 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 COL25A1 | 6.49e-41 | 41 | 47 | 20 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 2.23e-40 | 67 | 47 | 22 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 4.21e-37 | 90 | 47 | 22 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.45e-36 | 61 | 47 | 20 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 COL25A1 | 2.47e-34 | 76 | 47 | 20 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL25A1 | 1.01e-33 | 64 | 47 | 19 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL5A3 COL14A1 | 1.41e-29 | 61 | 47 | 17 | M27103 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL5A3 COL14A1 | 5.98e-29 | 50 | 47 | 16 | MM14796 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL14A1 | 2.75e-27 | 46 | 47 | 15 | M198 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL25A1 | 1.37e-26 | 140 | 47 | 19 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 6.99e-25 | 300 | 47 | 22 | M610 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL10A1 COL11A2 COL19A1 COL5A3 COL25A1 | 5.41e-24 | 53 | 47 | 14 | MM14566 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL14A1 | 9.23e-24 | 74 | 47 | 15 | M160 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 2.63e-23 | 20 | 47 | 11 | MM15061 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 COL25A1 | 5.33e-23 | 258 | 47 | 20 | MM14572 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL16A1 COL5A3 | 8.89e-23 | 85 | 47 | 15 | M16441 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL16A1 COL5A3 | 1.47e-21 | 76 | 47 | 14 | MM14867 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 1.80e-19 | 38 | 47 | 11 | MM14969 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL10A1 COL11A2 COL19A1 COL5A3 COL25A1 | 6.15e-19 | 114 | 47 | 14 | MM14571 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 6.36e-19 | 42 | 47 | 11 | M7169 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL10A1 COL11A2 COL5A3 | 3.72e-18 | 32 | 47 | 10 | MM14924 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 1.09e-17 | 76 | 47 | 12 | M27219 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 2.65e-17 | 57 | 47 | 11 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 3.26e-17 | 58 | 47 | 11 | M2049 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 8.71e-17 | 63 | 47 | 11 | M11187 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL10A1 COL11A2 COL5A3 | 3.40e-15 | 59 | 47 | 10 | M27218 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL5A2 COL6A3 COL7A1 COL11A2 | 7.27e-13 | 66 | 47 | 9 | M18 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.83e-12 | 15 | 47 | 6 | M27161 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 8.24e-11 | 10 | 47 | 5 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 8.24e-11 | 10 | 47 | 5 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.51e-10 | 11 | 47 | 5 | M15422 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.63e-10 | 47 | 47 | 7 | MM14925 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.58e-10 | 12 | 47 | 5 | MM1526 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.94e-10 | 84 | 47 | 8 | M7098 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 4.17e-10 | 13 | 47 | 5 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 4.17e-10 | 13 | 47 | 5 | M12950 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.51e-10 | 30 | 47 | 6 | M27216 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.48e-10 | 14 | 47 | 5 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.48e-10 | 14 | 47 | 5 | M6487 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 6.86e-10 | 261 | 47 | 11 | MM15676 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.69e-10 | 15 | 47 | 5 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.74e-09 | 18 | 47 | 5 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.74e-09 | 18 | 47 | 5 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 4.94e-09 | 20 | 47 | 5 | M15394 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL11A2 COL5A3 | 8.06e-09 | 418 | 47 | 12 | MM15587 |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.06e-08 | 23 | 47 | 5 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.06e-08 | 23 | 47 | 5 | MM1427 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL24A1 COL6A3 COL9A1 COL9A2 COL9A3 COL11A2 COL5A3 | 1.18e-08 | 532 | 47 | 13 | M27870 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.43e-08 | 30 | 47 | 5 | M27772 | |
| Pathway | WP_PI3KAKT_SIGNALING | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL6A3 COL9A1 COL9A2 COL9A3 | 1.33e-07 | 339 | 47 | 10 | M39736 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.27e-07 | 41 | 47 | 5 | M27778 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.69e-07 | 199 | 47 | 8 | M7253 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.90e-07 | 43 | 47 | 5 | M39565 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.05e-07 | 19 | 47 | 4 | MM15512 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 5.70e-07 | 502 | 47 | 11 | MM14537 |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 6.90e-07 | 6 | 47 | 3 | M39872 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 COL5A3 | 2.16e-06 | 575 | 47 | 11 | M29853 |
| Pathway | WP_FOCAL_ADHESION | 2.59e-06 | 187 | 47 | 7 | MM15913 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.79e-06 | 30 | 47 | 4 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.20e-06 | 79 | 47 | 5 | M27643 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL5A2 COL6A3 COL9A1 COL9A2 COL9A3 ARID1B KMT2D SALL1 SMARCC2 COL5A3 FOXO4 | 8.35e-06 | 1432 | 47 | 16 | M509 |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.22e-05 | 43 | 47 | 4 | M53 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.61e-05 | 96 | 47 | 5 | M39834 | |
| Pathway | WP_FOCAL_ADHESION | 4.87e-05 | 199 | 47 | 6 | M39402 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.83e-05 | 302 | 47 | 7 | M39719 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.13e-05 | 67 | 47 | 4 | MM15345 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 9.42e-05 | 326 | 47 | 7 | MM15917 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.90e-04 | 161 | 47 | 5 | M39770 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.79e-03 | 19 | 47 | 2 | M27221 | |
| Pathway | REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE | 2.41e-03 | 22 | 47 | 2 | M27933 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.74e-03 | 84 | 47 | 3 | M3228 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.36e-03 | 26 | 47 | 2 | MM14793 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.62e-03 | 27 | 47 | 2 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 3.89e-03 | 28 | 47 | 2 | MM15957 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.17e-03 | 29 | 47 | 2 | M48076 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 4.76e-03 | 31 | 47 | 2 | M39522 | |
| Pathway | WP_GASTRIC_CANCER_NETWORK_2 | 5.06e-03 | 32 | 47 | 2 | M39497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 6.04e-03 | 35 | 47 | 2 | M47969 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 6.73e-03 | 37 | 47 | 2 | M27797 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 8.61e-03 | 42 | 47 | 2 | M48237 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 8.61e-03 | 42 | 47 | 2 | M27272 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 9.83e-03 | 45 | 47 | 2 | M39864 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 1.20e-02 | 50 | 47 | 2 | M48087 | |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL16A1 COL19A1 COL21A1 COL14A1 COL25A1 | 2.93e-27 | 153 | 56 | 17 | 25037231 | |
| Pubmed | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A2 COL10A1 COL11A2 COL16A1 COL5A3 COL14A1 COL22A1 | 3.17e-26 | 175 | 56 | 17 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL11A2 COL16A1 COL21A1 COL5A3 COL14A1 | 4.36e-24 | 135 | 56 | 15 | 28675934 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL7A1 COL10A1 COL11A2 COL16A1 COL5A3 | 1.74e-22 | 62 | 56 | 12 | 28344315 |
| Pubmed | COL4A1 COL4A2 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A3 COL10A1 COL16A1 COL5A3 COL14A1 COL25A1 | 9.69e-21 | 167 | 56 | 14 | 22159717 | |
| Pubmed | COL2A1 COL4A3 COL4A6 COL5A2 COL7A1 COL9A1 COL9A2 COL10A1 COL11A2 COL16A1 COL19A1 BMP2K CSPG5 COL5A3 | 2.56e-19 | 210 | 56 | 14 | 16537572 | |
| Pubmed | 3.69e-16 | 8 | 56 | 6 | 10382266 | ||
| Pubmed | 3.69e-16 | 8 | 56 | 6 | 3997552 | ||
| Pubmed | 8.93e-15 | 25 | 56 | 7 | 19180518 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 5.40e-14 | 6 | 56 | 5 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 5.40e-14 | 6 | 56 | 5 | 9506531 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 8305476 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 5.40e-14 | 6 | 56 | 5 | 9673377 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 2426947 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 15922184 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 5.40e-14 | 6 | 56 | 5 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 5.40e-14 | 6 | 56 | 5 | 6811420 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 5.40e-14 | 6 | 56 | 5 | 19275937 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 5.40e-14 | 6 | 56 | 5 | 6389236 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 12225806 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 20301479 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 6.54e-14 | 15 | 56 | 6 | 9832566 | |
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 6.54e-14 | 15 | 56 | 6 | 10579729 | |
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.89e-13 | 7 | 56 | 5 | 8006028 | |
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 10416788 | ||
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 9426396 | ||
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 1724753 | ||
| Pubmed | 2.81e-13 | 39 | 56 | 7 | 33580754 | ||
| Pubmed | 3.53e-13 | 19 | 56 | 6 | 15689378 | ||
| Pubmed | 5.03e-13 | 8 | 56 | 5 | 9164858 | ||
| Pubmed | 5.03e-13 | 8 | 56 | 5 | 29422532 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 5.03e-13 | 8 | 56 | 5 | 10970885 | |
| Pubmed | 5.03e-13 | 8 | 56 | 5 | 1377218 | ||
| Pubmed | 1.13e-12 | 9 | 56 | 5 | 9878537 | ||
| Pubmed | 1.13e-12 | 9 | 56 | 5 | 12101409 | ||
| Pubmed | 2.26e-12 | 10 | 56 | 5 | 2446864 | ||
| Pubmed | 2.26e-12 | 10 | 56 | 5 | 9136074 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 3.81e-12 | 27 | 56 | 6 | 12192060 | |
| Pubmed | 4.13e-12 | 11 | 56 | 5 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 4.13e-12 | 11 | 56 | 5 | 7500359 | |
| Pubmed | Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. | 6.03e-12 | 4 | 56 | 4 | 8660302 | |
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 11724554 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 7.08e-12 | 12 | 56 | 5 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 7.08e-12 | 12 | 56 | 5 | 12180907 | |
| Pubmed | 7.08e-12 | 12 | 56 | 5 | 16024816 | ||
| Pubmed | 1.78e-11 | 14 | 56 | 5 | 12878203 | ||
| Pubmed | 3.01e-11 | 5 | 56 | 4 | 9409248 | ||
| Pubmed | Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. | 3.01e-11 | 5 | 56 | 4 | 16133074 | |
| Pubmed | 3.88e-11 | 16 | 56 | 5 | 15878328 | ||
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 7495302 | ||
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 9.02e-11 | 6 | 56 | 4 | 12883905 | |
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 17876790 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 9.26e-11 | 86 | 56 | 7 | 28327460 | |
| Pubmed | 1.80e-10 | 21 | 56 | 5 | 23325811 | ||
| Pubmed | Type II and type IX collagen transcript isoforms are expressed during mouse testis development. | 2.10e-10 | 7 | 56 | 4 | 12606408 | |
| Pubmed | 2.10e-10 | 7 | 56 | 4 | 10639489 | ||
| Pubmed | 2.10e-10 | 7 | 56 | 4 | 7521231 | ||
| Pubmed | Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene. | 2.10e-10 | 7 | 56 | 4 | 11527931 | |
| Pubmed | 2.10e-10 | 7 | 56 | 4 | 17418794 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 2.10e-10 | 7 | 56 | 4 | 10716744 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 4.20e-10 | 8 | 56 | 4 | 20059976 | |
| Pubmed | 5.78e-10 | 26 | 56 | 5 | 24742657 | ||
| Pubmed | 7.55e-10 | 9 | 56 | 4 | 8562707 | ||
| Pubmed | 1.26e-09 | 10 | 56 | 4 | 9415455 | ||
| Pubmed | 1.48e-09 | 31 | 56 | 5 | 22925884 | ||
| Pubmed | 1.97e-09 | 11 | 56 | 4 | 9664687 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 1.97e-09 | 11 | 56 | 4 | 9731539 | |
| Pubmed | 2.95e-09 | 12 | 56 | 4 | 8918877 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 3.36e-09 | 79 | 56 | 6 | 18757743 | |
| Pubmed | 3.88e-09 | 146 | 56 | 7 | 27068509 | ||
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 3.95e-09 | 3 | 56 | 3 | 19422682 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 26429145 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 3025878 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 20358595 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 3.95e-09 | 3 | 56 | 3 | 27377778 | |
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 3.95e-09 | 3 | 56 | 3 | 34049963 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 6386565 | ||
| Pubmed | Identification of a novel common genetic risk factor for lumbar disk disease. | 3.95e-09 | 3 | 56 | 3 | 11308397 | |
| Pubmed | The NC2 domain of type IX collagen determines the chain register of the triple helix. | 3.95e-09 | 3 | 56 | 3 | 23132862 | |
| Pubmed | Structural insight for chain selection and stagger control in collagen. | 3.95e-09 | 3 | 56 | 3 | 27897211 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 1429648 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 31090205 | ||
| Pubmed | Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan. | 3.95e-09 | 3 | 56 | 3 | 3473493 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 4.26e-09 | 13 | 56 | 4 | 9833687 | |
| Pubmed | 5.68e-09 | 40 | 56 | 5 | 27068110 | ||
| Pubmed | 5.96e-09 | 14 | 56 | 4 | 19858219 | ||
| Pubmed | 8.12e-09 | 15 | 56 | 4 | 10625553 | ||
| Pubmed | 8.12e-09 | 15 | 56 | 4 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 8.12e-09 | 15 | 56 | 4 | 10706142 | |
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 1.05e-08 | 45 | 56 | 5 | 34248495 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.17e-08 | 97 | 56 | 6 | 27559042 | |
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 1.41e-08 | 17 | 56 | 4 | 10213384 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 1.58e-08 | 4 | 56 | 3 | 7827955 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 15562585 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 23530037 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 23818951 | ||
| Pubmed | Mutations in collagen genes resulting in metaphyseal and epiphyseal dysplasias. | 1.58e-08 | 4 | 56 | 3 | 8579897 | |
| Interaction | COLGALT2 interactions | COL2A1 COL4A1 COL4A2 COL4A5 COL9A2 COL9A3 COL10A1 COL16A1 COL21A1 | 1.60e-13 | 67 | 55 | 9 | int:COLGALT2 |
| Interaction | LAIR2 interactions | 7.48e-13 | 49 | 55 | 8 | int:LAIR2 | |
| Interaction | MMP2 interactions | COL2A1 COL4A1 COL4A2 CCN5 COL4A6 COL5A2 COL6A3 COL7A1 COL14A1 | 1.84e-12 | 87 | 55 | 9 | int:MMP2 |
| Interaction | C1QTNF1 interactions | 4.39e-11 | 47 | 55 | 7 | int:C1QTNF1 | |
| Interaction | MMP9 interactions | 5.82e-10 | 67 | 55 | 7 | int:MMP9 | |
| Interaction | HABP2 interactions | 1.05e-09 | 18 | 55 | 5 | int:HABP2 | |
| Interaction | COL8A2 interactions | 1.52e-09 | 42 | 55 | 6 | int:COL8A2 | |
| Interaction | OSM interactions | 1.89e-09 | 20 | 55 | 5 | int:OSM | |
| Interaction | CD93 interactions | 2.34e-09 | 45 | 55 | 6 | int:CD93 | |
| Interaction | PLOD1 interactions | COL2A1 COL4A1 COL4A2 COL4A5 COL4A6 COL9A3 COL16A1 COL21A1 COL14A1 COL25A1 | 5.75e-09 | 292 | 55 | 10 | int:PLOD1 |
| Interaction | MAG interactions | 1.42e-08 | 29 | 55 | 5 | int:MAG | |
| Interaction | COL2A1 interactions | 2.07e-08 | 64 | 55 | 6 | int:COL2A1 | |
| Interaction | COL4A2 interactions | 5.44e-08 | 75 | 55 | 6 | int:COL4A2 | |
| Interaction | DCN interactions | 1.12e-07 | 43 | 55 | 5 | int:DCN | |
| Interaction | SERPINE2 interactions | 4.32e-07 | 56 | 55 | 5 | int:SERPINE2 | |
| Interaction | TPRX2 interactions | 4.32e-07 | 56 | 55 | 5 | int:TPRX2 | |
| Interaction | TGFBI interactions | 6.02e-07 | 25 | 55 | 4 | int:TGFBI | |
| Interaction | PLOD3 interactions | 6.37e-07 | 183 | 55 | 7 | int:PLOD3 | |
| Interaction | FBLN2 interactions | 9.90e-07 | 66 | 55 | 5 | int:FBLN2 | |
| Interaction | COL21A1 interactions | 1.60e-06 | 9 | 55 | 3 | int:COL21A1 | |
| Interaction | SP7 interactions | 1.61e-06 | 304 | 55 | 8 | int:SP7 | |
| Interaction | SOX7 interactions | 2.92e-06 | 82 | 55 | 5 | int:SOX7 | |
| Interaction | GSC interactions | 3.92e-06 | 87 | 55 | 5 | int:GSC | |
| Interaction | COL9A1 interactions | 5.40e-06 | 13 | 55 | 3 | int:COL9A1 | |
| Interaction | TLX1 interactions | 8.02e-06 | 175 | 55 | 6 | int:TLX1 | |
| Interaction | COL4A1 interactions | 8.84e-06 | 48 | 55 | 4 | int:COL4A1 | |
| Interaction | MATN2 interactions | 1.41e-05 | 113 | 55 | 5 | int:MATN2 | |
| Interaction | SAA1 interactions | 1.42e-05 | 54 | 55 | 4 | int:SAA1 | |
| Interaction | P4HA1 interactions | 1.59e-05 | 298 | 55 | 7 | int:P4HA1 | |
| Interaction | TBXT interactions | 1.60e-05 | 116 | 55 | 5 | int:TBXT | |
| Interaction | GATA2 interactions | 1.67e-05 | 199 | 55 | 6 | int:GATA2 | |
| Interaction | FEV interactions | 1.86e-05 | 203 | 55 | 6 | int:FEV | |
| Interaction | C1QTNF2 interactions | 2.46e-05 | 62 | 55 | 4 | int:C1QTNF2 | |
| Interaction | ERG interactions | 3.16e-05 | 223 | 55 | 6 | int:ERG | |
| Interaction | NFIX interactions | 3.50e-05 | 227 | 55 | 6 | int:NFIX | |
| Interaction | GCM1 interactions | 3.55e-05 | 68 | 55 | 4 | int:GCM1 | |
| Interaction | SOX15 interactions | 4.10e-05 | 141 | 55 | 5 | int:SOX15 | |
| Interaction | COL1A2 interactions | 6.10e-05 | 78 | 55 | 4 | int:COL1A2 | |
| Interaction | CRX interactions | 6.53e-05 | 254 | 55 | 6 | int:CRX | |
| Interaction | COL11A1 interactions | 6.68e-05 | 29 | 55 | 3 | int:COL11A1 | |
| Interaction | ANTXR2 interactions | 6.68e-05 | 29 | 55 | 3 | int:ANTXR2 | |
| Interaction | BGN interactions | 7.41e-05 | 30 | 55 | 3 | int:BGN | |
| Interaction | PAX2 interactions | 8.53e-05 | 85 | 55 | 4 | int:PAX2 | |
| Interaction | FN1 interactions | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL7A1 COL9A1 BMP2K BAG6 | 8.64e-05 | 848 | 55 | 10 | int:FN1 |
| Interaction | PDGFA interactions | 9.02e-05 | 32 | 55 | 3 | int:PDGFA | |
| Interaction | FOXI1 interactions | 1.16e-04 | 92 | 55 | 4 | int:FOXI1 | |
| Interaction | TEAD1 interactions | 1.17e-04 | 176 | 55 | 5 | int:TEAD1 | |
| Interaction | SOX17 interactions | 1.31e-04 | 95 | 55 | 4 | int:SOX17 | |
| Interaction | C1QTNF9 interactions | 1.40e-04 | 37 | 55 | 3 | int:C1QTNF9 | |
| Interaction | ALG13 interactions | 1.41e-04 | 183 | 55 | 5 | int:ALG13 | |
| Interaction | SOX9 interactions | 1.42e-04 | 97 | 55 | 4 | int:SOX9 | |
| Interaction | BMP3 interactions | 2.03e-04 | 8 | 55 | 2 | int:BMP3 | |
| Interaction | C1QC interactions | 2.05e-04 | 42 | 55 | 3 | int:C1QC | |
| Interaction | PAX8 interactions | 2.39e-04 | 111 | 55 | 4 | int:PAX8 | |
| Interaction | PRNP interactions | COL5A2 COL24A1 COL9A2 COL10A1 COL16A1 SGTA PURB IRF2BPL COL22A1 COL25A1 BAG6 | 2.49e-04 | 1158 | 55 | 11 | int:PRNP |
| Interaction | TBR1 interactions | 2.56e-04 | 113 | 55 | 4 | int:TBR1 | |
| Interaction | COL9A3 interactions | 3.25e-04 | 10 | 55 | 2 | int:COL9A3 | |
| Interaction | PAX7 interactions | 3.65e-04 | 124 | 55 | 4 | int:PAX7 | |
| Interaction | MEN1 interactions | PRR12 ZHX3 ARID1B KMT2D PNPLA6 WDR33 PURB PITX3 SMARCC2 IRF2BPL | 4.14e-04 | 1029 | 55 | 10 | int:MEN1 |
| Interaction | PAX9 interactions | 4.37e-04 | 130 | 55 | 4 | int:PAX9 | |
| Interaction | PAX6 interactions | 4.71e-04 | 366 | 55 | 6 | int:PAX6 | |
| Interaction | TLE3 interactions | 5.43e-04 | 376 | 55 | 6 | int:TLE3 | |
| Interaction | PHF10 interactions | 5.63e-04 | 139 | 55 | 4 | int:PHF10 | |
| Interaction | EDAR interactions | 7.12e-04 | 64 | 55 | 3 | int:EDAR | |
| Interaction | COL5A1 interactions | 7.45e-04 | 65 | 55 | 3 | int:COL5A1 | |
| Interaction | BICRA interactions | 8.14e-04 | 67 | 55 | 3 | int:BICRA | |
| Interaction | ETV4 interactions | 8.87e-04 | 69 | 55 | 3 | int:ETV4 | |
| Interaction | HNF4A interactions | 9.09e-04 | 275 | 55 | 5 | int:HNF4A | |
| Interaction | COL9A2 interactions | 9.69e-04 | 17 | 55 | 2 | int:COL9A2 | |
| Interaction | C1QL4 interactions | 1.05e-03 | 73 | 55 | 3 | int:C1QL4 | |
| Interaction | SERPINI2 interactions | 1.09e-03 | 18 | 55 | 2 | int:SERPINI2 | |
| Interaction | COL16A1 interactions | 1.09e-03 | 18 | 55 | 2 | int:COL16A1 | |
| Interaction | TLX3 interactions | 1.17e-03 | 291 | 55 | 5 | int:TLX3 | |
| Interaction | SS18L2 interactions | 1.17e-03 | 76 | 55 | 3 | int:SS18L2 | |
| Interaction | EGR2 interactions | 1.22e-03 | 171 | 55 | 4 | int:EGR2 | |
| Interaction | C1QA interactions | 1.22e-03 | 77 | 55 | 3 | int:C1QA | |
| Interaction | FGL1 interactions | 1.22e-03 | 77 | 55 | 3 | int:FGL1 | |
| Interaction | COMP interactions | 1.35e-03 | 20 | 55 | 2 | int:COMP | |
| Interaction | TEX13B interactions | 1.35e-03 | 20 | 55 | 2 | int:TEX13B | |
| Interaction | SRGN interactions | 1.35e-03 | 20 | 55 | 2 | int:SRGN | |
| Interaction | LHX2 interactions | 1.56e-03 | 183 | 55 | 4 | int:LHX2 | |
| Interaction | ANXA7 interactions | 1.60e-03 | 184 | 55 | 4 | int:ANXA7 | |
| Interaction | IRF4 interactions | 1.62e-03 | 85 | 55 | 3 | int:IRF4 | |
| Interaction | LHX3 interactions | 1.63e-03 | 185 | 55 | 4 | int:LHX3 | |
| Interaction | GATA3 interactions | 1.69e-03 | 187 | 55 | 4 | int:GATA3 | |
| Interaction | FKBP9 interactions | 1.73e-03 | 87 | 55 | 3 | int:FKBP9 | |
| Interaction | SMG7 interactions | 1.75e-03 | 319 | 55 | 5 | int:SMG7 | |
| Interaction | SS18 interactions | 1.79e-03 | 88 | 55 | 3 | int:SS18 | |
| Interaction | HNF1B interactions | 1.79e-03 | 190 | 55 | 4 | int:HNF1B | |
| Interaction | COL6A2 interactions | 1.91e-03 | 90 | 55 | 3 | int:COL6A2 | |
| Interaction | MYOD1 interactions | 1.94e-03 | 194 | 55 | 4 | int:MYOD1 | |
| Cytoband | Xq22 | 3.32e-04 | 22 | 56 | 2 | Xq22 | |
| Cytoband | 13q34 | 2.01e-03 | 54 | 56 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q13 | 2.98e-03 | 66 | 56 | 2 | chr6q13 | |
| GeneFamily | Collagens | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 2.02e-48 | 46 | 43 | 22 | 490 |
| GeneFamily | Collagens|Collagen proteoglycans | 1.25e-07 | 5 | 43 | 3 | 575 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 3.09e-49 | 44 | 56 | 22 | M3005 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.16e-46 | 43 | 56 | 21 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 CCN5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 2.76e-31 | 275 | 56 | 23 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 CCN5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.26e-29 | 270 | 56 | 22 | MM17057 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 CCN5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 CSPG5 COL5A3 COL14A1 COL22A1 COL25A1 | 1.70e-19 | 1026 | 56 | 24 | M5889 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 CCN5 COL4A6 COL5A2 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 CSPG5 COL5A3 COL14A1 COL22A1 COL25A1 | 2.11e-18 | 1008 | 56 | 23 | MM17056 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 3.30e-11 | 29 | 56 | 6 | MM17055 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.65e-10 | 71 | 56 | 7 | M3955 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.62e-10 | 40 | 56 | 6 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.21e-09 | 23 | 56 | 5 | M48001 | |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 9.13e-09 | 12 | 56 | 4 | MM3646 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | COL4A1 COL4A2 COL4A6 COL7A1 COL9A1 COL16A1 CELSR2 WDR33 COL14A1 GLIS1 | 8.30e-08 | 493 | 56 | 10 | M19391 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 1.38e-07 | 111 | 56 | 6 | M45685 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.29e-07 | 200 | 56 | 7 | M5930 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 3.49e-07 | 68 | 56 | 5 | M45669 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 5.34e-07 | 74 | 56 | 5 | M13547 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 COL4A2 CCN5 COL5A2 COL6A3 COL7A1 COL16A1 COL21A1 COL5A3 COL14A1 PYGO1 | 5.62e-07 | 767 | 56 | 11 | M39209 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 8.40e-07 | 81 | 56 | 5 | M39253 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A1 COL4A2 COL4A5 COL4A6 COL5A2 COL6A3 SALL1 COL5A3 COL14A1 | 1.16e-06 | 505 | 56 | 9 | M39167 |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.51e-06 | 11 | 56 | 3 | M47997 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 2.38e-06 | 44 | 56 | 4 | M18274 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 5.18e-06 | 117 | 56 | 5 | M39300 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 5.18e-06 | 117 | 56 | 5 | M45663 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 5.86e-06 | 120 | 56 | 5 | M42505 | |
| Coexpression | KANG_AR_TARGETS_UP | 6.15e-06 | 17 | 56 | 3 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 6.15e-06 | 17 | 56 | 3 | M2223 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 6.15e-06 | 17 | 56 | 3 | M47995 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 9.78e-06 | 352 | 56 | 7 | M17471 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | COL4A1 COL4A5 COL9A1 COL11A2 COL16A1 COL19A1 BMP2K COL5A3 COL14A1 COL22A1 RELT | 1.19e-05 | 1054 | 56 | 11 | M45798 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | 2.20e-05 | 554 | 56 | 8 | M2244 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.29e-05 | 268 | 56 | 6 | M45796 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 2.61e-05 | 27 | 56 | 3 | M47994 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.70e-05 | 276 | 56 | 6 | M3063 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 3.03e-05 | 83 | 56 | 4 | M2448 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 4.46e-05 | 5 | 56 | 2 | M47996 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 5.65e-05 | 192 | 56 | 5 | M42501 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 5.76e-05 | 35 | 56 | 3 | MM17054 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | COL2A1 COL4A5 COL4A6 ZNF703 COL24A1 COL9A2 BARHL2 PITX3 FOXO4 COL25A1 | 6.02e-05 | 1035 | 56 | 10 | M9898 |
| Coexpression | BENPORATH_PRC2_TARGETS | 6.81e-05 | 650 | 56 | 8 | M8448 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP | 6.85e-05 | 200 | 56 | 5 | M8328 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.97e-05 | 479 | 56 | 7 | M2573 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE | 7.02e-05 | 201 | 56 | 5 | MM17086 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.34e-05 | 483 | 56 | 7 | MM1082 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 9.30e-05 | 41 | 56 | 3 | M47988 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 1.03e-04 | 218 | 56 | 5 | M1099 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.34e-04 | 369 | 56 | 6 | MM16610 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.40e-04 | 47 | 56 | 3 | M7585 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 1.46e-04 | 235 | 56 | 5 | MM978 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 1.49e-04 | 48 | 56 | 3 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 1.49e-04 | 48 | 56 | 3 | MM1088 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 1.57e-04 | 380 | 56 | 6 | M45714 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.69e-04 | 50 | 56 | 3 | M1259 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 1.69e-04 | 50 | 56 | 3 | M7337 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 1.69e-04 | 50 | 56 | 3 | M2485 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.69e-04 | 385 | 56 | 6 | M39264 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.90e-04 | 52 | 56 | 3 | MM1118 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 1.98e-04 | 567 | 56 | 7 | M1097 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 2.17e-04 | 256 | 56 | 5 | M10952 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 2.24e-04 | 55 | 56 | 3 | MM3666 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.38e-04 | 261 | 56 | 5 | M1834 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 2.76e-04 | 59 | 56 | 3 | MM952 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_DN | 2.90e-04 | 60 | 56 | 3 | MM761 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_DN | 2.90e-04 | 60 | 56 | 3 | M1797 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 2.90e-04 | 60 | 56 | 3 | M16524 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 2.92e-04 | 12 | 56 | 2 | M47983 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 3.27e-04 | 616 | 56 | 7 | MM977 | |
| Coexpression | DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP | 3.44e-04 | 13 | 56 | 2 | M13055 | |
| Coexpression | BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN | 3.44e-04 | 13 | 56 | 2 | M17068 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 3.51e-04 | 64 | 56 | 3 | M2572 | |
| Coexpression | LI_ESTROGENE_META_E2_RESPONSE_UP | 3.67e-04 | 65 | 56 | 3 | M48211 | |
| Coexpression | BENPORATH_EED_TARGETS | COL2A1 COL4A5 COL4A6 COL24A1 COL9A2 COL19A1 BARHL2 PITX3 COL25A1 | 3.80e-04 | 1059 | 56 | 9 | M7617 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 4.02e-04 | 162 | 56 | 4 | M45037 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 4.12e-04 | 163 | 56 | 4 | M2769 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 4.20e-04 | 68 | 56 | 3 | M1373 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 4.62e-04 | 15 | 56 | 2 | MM402 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 4.96e-04 | 72 | 56 | 3 | MM1131 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A5 COL4A6 ZNF703 COL6A3 COL9A1 COL11A2 COL16A1 DDHD1 KIFC2 | 5.07e-04 | 1102 | 56 | 9 | M2369 |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 5.17e-04 | 73 | 56 | 3 | M6939 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 5.46e-04 | 313 | 56 | 5 | M40228 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A5 COL4A6 ZNF703 COL6A3 COL9A1 COL11A2 COL16A1 DDHD1 KIFC2 | 5.85e-04 | 1124 | 56 | 9 | MM1070 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 5.86e-04 | 179 | 56 | 4 | M39308 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN | 6.04e-04 | 77 | 56 | 3 | M17937 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 6.51e-04 | 79 | 56 | 3 | M18400 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 6.71e-04 | 18 | 56 | 2 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 6.71e-04 | 18 | 56 | 2 | M13796 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 6.71e-04 | 18 | 56 | 2 | M47984 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 6.75e-04 | 80 | 56 | 3 | MM1285 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP | 7.76e-04 | 193 | 56 | 4 | M8394 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 7.91e-04 | 194 | 56 | 4 | M39122 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP | 8.22e-04 | 196 | 56 | 4 | M8858 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP | 8.38e-04 | 197 | 56 | 4 | M7939 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP | 8.54e-04 | 198 | 56 | 4 | M5215 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP | 8.54e-04 | 198 | 56 | 4 | M6232 | |
| Coexpression | GSE27786_LSK_VS_CD8_TCELL_UP | 8.70e-04 | 199 | 56 | 4 | M4749 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 8.70e-04 | 199 | 56 | 4 | M7319 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | 8.86e-04 | 200 | 56 | 4 | M3365 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP | 8.86e-04 | 200 | 56 | 4 | M5807 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 8.86e-04 | 200 | 56 | 4 | M8088 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 8.86e-04 | 200 | 56 | 4 | M331 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP | 8.86e-04 | 200 | 56 | 4 | M9737 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 3.07e-05 | 69 | 55 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | COL2A1 ZNF703 COL24A1 COL6A3 COL7A1 COL9A1 COL16A1 WDR33 COL14A1 COL25A1 GTF2IRD1 | 3.47e-05 | 978 | 55 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 4.17e-05 | 501 | 55 | 8 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 4.17e-05 | 501 | 55 | 8 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 4.17e-05 | 501 | 55 | 8 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.63e-05 | 371 | 55 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL7A1 COL9A1 COL9A2 COL9A3 ARID1B SALL1 CELSR2 ZNF268 CSPG5 COL22A1 COL25A1 | 6.55e-05 | 1245 | 55 | 12 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | COL5A2 ZHX3 COL24A1 COL6A3 COL9A2 COL9A3 SMARCC2 GLIS1 PYGO1 | 9.44e-05 | 726 | 55 | 9 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL4A1 COL4A2 COL6A3 COL11A2 BARHL2 COL5A3 COL25A1 GLIS1 PYGO1 | 1.45e-04 | 951 | 55 | 10 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.56e-04 | 197 | 55 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | COL2A1 ZNF703 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL16A1 COL14A1 COL25A1 | 1.66e-04 | 967 | 55 | 10 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 1.74e-04 | 320 | 55 | 6 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A2 ZNF703 COL9A2 GLIS1 PYGO1 | 1.88e-04 | 982 | 55 | 10 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | COL2A1 COL24A1 COL6A3 COL7A1 COL16A1 SALL1 CELSR2 COL14A1 IRF2BPL COL25A1 | 1.91e-04 | 984 | 55 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.29e-04 | 480 | 55 | 7 | ratio_MESO_vs_SC_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 2.57e-04 | 489 | 55 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.66e-04 | 655 | 55 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A2 COL4A5 COL4A6 COL5A2 ZNF703 COL7A1 COL9A2 CELSR2 SMARCC2 COL22A1 GTF2IRD1 | 3.05e-04 | 1466 | 55 | 12 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.96e-04 | 241 | 55 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.13e-04 | 529 | 55 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.19e-04 | 244 | 55 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#1 | 4.38e-04 | 137 | 55 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 4.38e-04 | 137 | 55 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL4A1 COL4A2 COL5A2 ZNF703 COL6A3 COL9A2 BARHL2 COL5A3 PYGO1 | 4.45e-04 | 1094 | 55 | 10 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 5.15e-04 | 143 | 55 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.68e-04 | 734 | 55 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 6.70e-04 | 66 | 55 | 3 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_500 | |
| CoexpressionAtlas | BM Top 100 - cervix | 6.70e-04 | 66 | 55 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.32e-04 | 276 | 55 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 7.48e-04 | 421 | 55 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.80e-04 | 589 | 55 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.96e-04 | 591 | 55 | 7 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 7.96e-04 | 70 | 55 | 3 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL9A3 COL16A1 CELSR2 DDHD1 COL14A1 COL25A1 GLIS1 | 8.17e-04 | 973 | 55 | 9 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL7A1 COL16A1 SALL1 CELSR2 BARHL2 COL14A1 COL25A1 | 8.35e-04 | 976 | 55 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 8.64e-04 | 72 | 55 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL2A1 COL24A1 COL6A3 COL9A1 COL21A1 BARHL2 COL5A3 COL25A1 GLIS1 | 8.66e-04 | 981 | 55 | 9 | Arv_EB-LF_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL2A1 COL6A3 COL9A1 COL11A2 COL21A1 CSPG5 BARHL2 COL14A1 PYGO1 | 8.98e-04 | 986 | 55 | 9 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | BM Top 100 - coronary artery | 9.00e-04 | 73 | 55 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 9.36e-04 | 74 | 55 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | COL2A1 COL24A1 COL6A3 COL9A1 COL9A2 COL11A2 COL21A1 CSPG5 BARHL2 | 9.37e-04 | 992 | 55 | 9 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | COL2A1 COL6A3 COL9A1 COL21A1 CSPG5 BARHL2 COL14A1 COL25A1 PYGO1 | 9.50e-04 | 994 | 55 | 9 | PCBC_EB_1000 |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.06e-03 | 300 | 55 | 5 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.09e-03 | 78 | 55 | 3 | PCBC_ratio_DE_from-OSKM_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.30e-03 | 834 | 55 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 1.32e-03 | 836 | 55 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.44e-03 | 848 | 55 | 8 | ratio_ECTO_vs_SC_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.44e-03 | 655 | 55 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | 1.52e-03 | 483 | 55 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 1.56e-03 | 486 | 55 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_500 | 1.57e-03 | 193 | 55 | 4 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.58e-03 | 487 | 55 | 6 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 1.61e-03 | 489 | 55 | 6 | PCBC_MESO-5_fibroblast_500 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A5 ZNF703 COL7A1 COL9A1 PNPLA6 CELSR2 SMARCC2 COL22A1 | 1.64e-03 | 1075 | 55 | 9 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_top-relative-expression-ranked_500 | 1.65e-03 | 491 | 55 | 6 | PCBC_MESO-5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.66e-03 | 196 | 55 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.66e-03 | 492 | 55 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.69e-03 | 197 | 55 | 4 | gudmap_developingGonad_e11.5_testes_k2_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 1.73e-03 | 496 | 55 | 6 | PCBC_EB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 1.75e-03 | 497 | 55 | 6 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#5_top-relative-expression-ranked_500 | 1.75e-03 | 24 | 55 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.80e-03 | 878 | 55 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.92e-03 | 95 | 55 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 1.99e-03 | 206 | 55 | 4 | JC_fibro_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.03e-03 | 207 | 55 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_100 | 2.04e-03 | 97 | 55 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_100 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A1 PTOV1 COL4A2 COL4A5 COL5A2 COL6A3 COL11A2 COL16A1 COL5A3 COL14A1 | 1.13e-15 | 198 | 56 | 11 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A2 COL4A5 COL4A6 COL5A2 COL24A1 COL6A3 COL16A1 COL5A3 COL14A1 | 2.05e-12 | 188 | 56 | 9 | b382d18fb09fb2869f3c151efa71540a7f5ed229 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-12 | 188 | 56 | 9 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL2A1 COL24A1 COL6A3 COL9A1 COL9A2 COL9A3 COL11A2 COL16A1 GLIS1 | 2.05e-12 | 188 | 56 | 9 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | COL4A1 COL4A2 COL7A1 COL9A1 COL9A2 COL9A3 PLA2G3 COL14A1 COL22A1 | 2.36e-12 | 191 | 56 | 9 | 409e12d2bb26b6d2ed025304ca6ace07df16638a |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | COL4A1 COL4A2 CCN5 COL5A2 COL6A3 COL10A1 COL16A1 COL5A3 COL14A1 | 2.98e-12 | 196 | 56 | 9 | 275e153347caf94edc0c50021bbab49c8696fecb |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 2.51e-11 | 159 | 56 | 8 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-11 | 166 | 56 | 8 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-11 | 166 | 56 | 8 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.92e-11 | 177 | 56 | 8 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 8.07e-11 | 184 | 56 | 8 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.42e-11 | 185 | 56 | 8 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.79e-11 | 186 | 56 | 8 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.09e-10 | 191 | 56 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-10 | 195 | 56 | 8 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-10 | 197 | 56 | 8 | 8786125b669d5d0b15e12df0ade6b319f09f7333 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-10 | 198 | 56 | 8 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-10 | 198 | 56 | 8 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-10 | 198 | 56 | 8 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-10 | 198 | 56 | 8 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-10 | 198 | 56 | 8 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-10 | 199 | 56 | 8 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-10 | 199 | 56 | 8 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-10 | 199 | 56 | 8 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 1.51e-10 | 199 | 56 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-10 | 199 | 56 | 8 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-10 | 200 | 56 | 8 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-10 | 200 | 56 | 8 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-10 | 200 | 56 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.57e-10 | 200 | 56 | 8 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-10 | 200 | 56 | 8 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-10 | 200 | 56 | 8 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-10 | 200 | 56 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-10 | 200 | 56 | 8 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-10 | 200 | 56 | 8 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-10 | 200 | 56 | 8 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.57e-10 | 200 | 56 | 8 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.32e-09 | 161 | 56 | 7 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.50e-09 | 164 | 56 | 7 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.01e-09 | 171 | 56 | 7 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-09 | 176 | 56 | 7 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-09 | 177 | 56 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-09 | 177 | 56 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.10e-09 | 182 | 56 | 7 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-09 | 183 | 56 | 7 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 3.34e-09 | 184 | 56 | 7 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.47e-09 | 185 | 56 | 7 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.88e-09 | 188 | 56 | 7 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.49e-09 | 192 | 56 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-09 | 192 | 56 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.65e-09 | 193 | 56 | 7 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-09 | 193 | 56 | 7 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.65e-09 | 193 | 56 | 7 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-09 | 193 | 56 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-09 | 193 | 56 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.82e-09 | 194 | 56 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 5.00e-09 | 195 | 56 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-09 | 195 | 56 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-09 | 195 | 56 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 5.18e-09 | 196 | 56 | 7 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-09 | 196 | 56 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-09 | 197 | 56 | 7 | 6e111ba16fc8adde782b3f7da250248cddf11228 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-09 | 197 | 56 | 7 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-09 | 197 | 56 | 7 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-09 | 197 | 56 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-09 | 197 | 56 | 7 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-09 | 197 | 56 | 7 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-09 | 197 | 56 | 7 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.55e-09 | 198 | 56 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-09 | 198 | 56 | 7 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-09 | 198 | 56 | 7 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.55e-09 | 198 | 56 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-09 | 198 | 56 | 7 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-09 | 198 | 56 | 7 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-09 | 198 | 56 | 7 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.55e-09 | 198 | 56 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 5.75e-09 | 199 | 56 | 7 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 5.75e-09 | 199 | 56 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.75e-09 | 199 | 56 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-09 | 199 | 56 | 7 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.75e-09 | 199 | 56 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.75e-09 | 199 | 56 | 7 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.75e-09 | 199 | 56 | 7 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.95e-09 | 200 | 56 | 7 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.95e-09 | 200 | 56 | 7 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.95e-09 | 200 | 56 | 7 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-09 | 200 | 56 | 7 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.95e-09 | 200 | 56 | 7 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.95e-09 | 200 | 56 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | distal-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.95e-09 | 200 | 56 | 7 | 65a50f03b0027ccefb51b8f77afa283d4a3b3567 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.95e-09 | 200 | 56 | 7 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | medial-mesenchymal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.95e-09 | 200 | 56 | 7 | 4f19e1e40966e27779bf77e8c170ed3ecc24353e | |
| ToppCell | distal-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.95e-09 | 200 | 56 | 7 | 4ee0b2f56c2652435fa78bf6b3c90cea28df74e0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.95e-09 | 200 | 56 | 7 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.61e-08 | 157 | 56 | 6 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.79e-08 | 158 | 56 | 6 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.65e-08 | 167 | 56 | 6 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.14e-08 | 169 | 56 | 6 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 7.14e-08 | 169 | 56 | 6 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 7.66e-08 | 171 | 56 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| Computational | Adhesion molecules. | COL4A1 COL4A5 COL5A2 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL16A1 | 1.40e-10 | 141 | 31 | 9 | MODULE_122 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-05 | 50 | 31 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.88e-04 | 50 | 31 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.88e-04 | 50 | 31 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.88e-04 | 50 | 31 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | ECM and collagens. | 4.19e-04 | 225 | 31 | 5 | MODULE_47 | |
| Drug | GK-101 | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 3.03e-39 | 36 | 55 | 18 | CID000161853 |
| Drug | Madecassol | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 9.28e-37 | 46 | 55 | 18 | CID000108062 |
| Drug | AC1LAKND | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 2.24e-36 | 62 | 55 | 19 | CID000470146 |
| Drug | d-indobufen | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 5.90e-36 | 50 | 55 | 18 | CID000044562 |
| Drug | ridogrel | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.39e-35 | 52 | 55 | 18 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 2.10e-35 | 53 | 55 | 18 | CID000023340 |
| Drug | BAPN | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 4.48e-35 | 71 | 55 | 19 | CID000001647 |
| Drug | halofuginone lactate | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 2.15e-33 | 85 | 55 | 19 | CID000062891 |
| Drug | 4-hydroxyproline | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 9.10e-33 | 91 | 55 | 19 | CID000000825 |
| Drug | malotilate | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 9.84e-33 | 71 | 55 | 18 | CID000004006 |
| Drug | AC1NMZ1B | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 3.01e-32 | 75 | 55 | 18 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 5.13e-32 | 77 | 55 | 18 | CID006918182 |
| Drug | ticlopidine | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.21e-31 | 103 | 55 | 19 | CID000005472 |
| Drug | DMSe | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 CELSR2 COL21A1 COL5A3 COL14A1 COL22A1 COL25A1 | 1.75e-31 | 132 | 55 | 20 | CID000020796 |
| Drug | hydroxylysine | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 3.90e-31 | 109 | 55 | 19 | CID000001029 |
| Drug | Tranilast sodium | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.17e-30 | 115 | 55 | 19 | CID000005527 |
| Drug | pirfenidone | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 4.76e-29 | 138 | 55 | 19 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 5.51e-29 | 139 | 55 | 19 | CID000004727 |
| Drug | PCR 4099 | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 5.51e-29 | 139 | 55 | 19 | CID000002806 |
| Drug | AC1L1C2F | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 5.94e-29 | 110 | 55 | 18 | CID000001711 |
| Drug | PPACK | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.00e-28 | 113 | 55 | 18 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.19e-28 | 114 | 55 | 18 | CID000439300 |
| Drug | Selara | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 6.98e-28 | 125 | 55 | 18 | CID000150310 |
| Drug | khellin | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 3.46e-27 | 171 | 55 | 19 | CID000003828 |
| Drug | AC1L1DD6 | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 8.54e-27 | 179 | 55 | 19 | CID000002299 |
| Drug | candesartan cilexetil | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.18e-26 | 145 | 55 | 18 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 9.52e-26 | 162 | 55 | 18 | CID000072363 |
| Drug | AC1Q6PCP | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.16e-24 | 230 | 55 | 19 | CID000005267 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.69e-24 | 189 | 55 | 18 | CID000001413 |
| Drug | foscarnet | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.87e-24 | 190 | 55 | 18 | CID000003414 |
| Drug | hyaluronan | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.56e-23 | 263 | 55 | 19 | CID000024759 |
| Drug | AC1L18QD | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 PLA2G3 COL14A1 COL22A1 COL25A1 | 2.21e-23 | 325 | 55 | 20 | CID000000213 |
| Drug | silibinin | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 7.30e-23 | 285 | 55 | 19 | CID000005213 |
| Drug | prostacyclin sodium salt | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 2.91e-22 | 250 | 55 | 18 | CID000000159 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 SALL1 COL21A1 COL14A1 COL22A1 COL25A1 | 4.66e-22 | 314 | 55 | 19 | CID000447989 |
| Drug | chondroitin sulfate | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 CSPG5 COL14A1 COL22A1 COL25A1 | 2.66e-21 | 413 | 55 | 20 | CID000024766 |
| Drug | losartan | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.58e-20 | 378 | 55 | 19 | CID000003961 |
| Drug | colchine | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 2.02e-20 | 383 | 55 | 19 | CID000002833 |
| Drug | AC1L1KMJ | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 1.20e-18 | 476 | 55 | 19 | CID000030956 |
| Drug | Y-27632 | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 8.78e-18 | 444 | 55 | 18 | CID000005711 |
| Drug | aspirin | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 COL14A1 COL22A1 COL25A1 | 2.69e-17 | 563 | 55 | 19 | CID000002244 |
| Drug | LMWH | COL2A1 COL4A1 COL4A3 COL4A5 CCN5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL21A1 COL14A1 COL22A1 COL25A1 | 5.39e-16 | 663 | 55 | 19 | CID000000772 |
| Drug | LS-63783 | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL24A1 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL11A2 COL16A1 COL19A1 COL21A1 PLA2G3 COL14A1 COL22A1 COL25A1 | 1.14e-15 | 804 | 55 | 20 | CID000000231 |
| Drug | L-3,4-dehydroproline | COL2A1 COL6A3 COL7A1 COL9A3 COL10A1 COL16A1 COL19A1 COL21A1 COL22A1 COL25A1 | 1.58e-15 | 73 | 55 | 10 | CID000094284 |
| Drug | NC-4 | 1.16e-11 | 44 | 55 | 7 | CID006420119 | |
| Drug | 1zd2 | 1.37e-11 | 45 | 55 | 7 | CID004149241 | |
| Drug | NSC-333492 | 3.05e-11 | 4 | 55 | 4 | CID000333256 | |
| Drug | dermatan sulfate | COL2A1 COL4A3 COL4A5 COL6A3 COL9A1 COL9A2 COL9A3 COL11A2 COL21A1 | 2.70e-09 | 220 | 55 | 9 | CID000032756 |
| Drug | pyridinoline | 4.05e-09 | 99 | 55 | 7 | CID000105068 | |
| Drug | 1h00 | 4.44e-09 | 56 | 55 | 6 | CID000445950 | |
| Drug | CP-331 | 1.33e-08 | 3 | 55 | 3 | CID000130967 | |
| Drug | diphenylamine-2-carboxylate | 1.34e-07 | 164 | 55 | 7 | CID000004386 | |
| Drug | In2-7 | 2.65e-07 | 6 | 55 | 3 | CID002816385 | |
| Drug | etodolac | 1.04e-06 | 32 | 55 | 4 | CID000003308 | |
| Drug | isodesmosine | 1.18e-06 | 33 | 55 | 4 | CID000013811 | |
| Drug | Span 40 | 4.76e-06 | 14 | 55 | 3 | CID000014927 | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 7.26e-06 | 194 | 55 | 6 | 6741_UP | |
| Drug | desmosine | 8.17e-06 | 53 | 55 | 4 | CID000025435 | |
| Drug | B-F-H | 1.48e-05 | 20 | 55 | 3 | CID000027690 | |
| Drug | 351A | 1.48e-05 | 20 | 55 | 3 | CID000122144 | |
| Drug | pyrachlostrobin | COL4A1 COL4A5 CCN5 COL4A6 COL5A2 COL16A1 COL19A1 COL5A3 COL22A1 KIFC2 | 2.13e-05 | 811 | 55 | 10 | ctd:C513428 |
| Drug | calcium pyrophosphate | 3.09e-05 | 74 | 55 | 4 | CID000024632 | |
| Drug | Brn 2557402 | 3.43e-05 | 4 | 55 | 2 | CID000042742 | |
| Drug | sodium chloride | COL4A3 COL4A5 COL6A3 COL7A1 COL9A1 COL9A2 COL9A3 COL10A1 COL21A1 COL25A1 | 3.68e-05 | 865 | 55 | 10 | CID000000206 |
| Drug | toluidine blue | 4.63e-05 | 82 | 55 | 4 | CID000007083 | |
| Drug | dimethylmalonimidate | 5.70e-05 | 5 | 55 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 5.70e-05 | 5 | 55 | 2 | CID006449872 | |
| Drug | sodium dodecyl sulfate | 6.97e-05 | 91 | 55 | 4 | CID000008778 | |
| Drug | AC1L9HPX | 7.27e-05 | 92 | 55 | 4 | CID000445279 | |
| Drug | Sirius red | 8.26e-05 | 35 | 55 | 3 | CID005486818 | |
| Drug | BPAT-143 | 8.54e-05 | 6 | 55 | 2 | CID000146249 | |
| Drug | 4-fluoranylproline | 8.54e-05 | 6 | 55 | 2 | CID000450594 | |
| Drug | Diphosphonates | 8.54e-05 | 6 | 55 | 2 | ctd:D004164 | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 9.29e-05 | 189 | 55 | 5 | 882_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.03e-04 | 193 | 55 | 5 | 4477_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 194 | 55 | 5 | 3610_UP | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 1.08e-04 | 195 | 55 | 5 | 2425_UP | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.08e-04 | 195 | 55 | 5 | 6299_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 3682_UP | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; PC3; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 4225_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 7300_UP | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 4150_UP | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 5246_UP | |
| Drug | AC1MRIIV | 1.15e-04 | 39 | 55 | 3 | CID003518584 | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 6137_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.18e-04 | 199 | 55 | 5 | 3606_UP | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.18e-04 | 199 | 55 | 5 | 6735_UP | |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.18e-04 | 199 | 55 | 5 | 3805_UP | |
| Drug | AC1L1HWN | 1.19e-04 | 7 | 55 | 2 | CID000004323 | |
| Drug | hydroxyl radical | 1.39e-04 | 206 | 55 | 5 | CID000157350 | |
| Drug | balofloxacin | 1.43e-04 | 42 | 55 | 3 | CID000065958 | |
| Drug | PD123177 | 1.54e-04 | 43 | 55 | 3 | CID000114899 | |
| Drug | NSC27366 | 1.59e-04 | 8 | 55 | 2 | CID000231329 | |
| Drug | Sc 40827 | 1.59e-04 | 8 | 55 | 2 | CID000127918 | |
| Drug | alpha-methyl-D-mannoside | 1.79e-04 | 116 | 55 | 4 | CID000002108 | |
| Drug | mofezolac | 2.04e-04 | 9 | 55 | 2 | ctd:C054999 | |
| Drug | safranin | 2.41e-04 | 50 | 55 | 3 | CID002723800 | |
| Drug | 2,3-pentanedione | 2.68e-04 | 129 | 55 | 4 | ctd:C013186 | |
| Drug | gold nanoparticles | 2.99e-04 | 243 | 55 | 5 | CID000023985 | |
| Drug | MBMP | 3.11e-04 | 11 | 55 | 2 | CID000150994 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 9.43e-13 | 19 | 56 | 6 | DOID:2256 (is_implicated_in) | |
| Disease | Stickler syndrome (is_implicated_in) | 1.16e-11 | 4 | 56 | 4 | DOID:0080046 (is_implicated_in) | |
| Disease | Stickler syndrome | 5.81e-11 | 5 | 56 | 4 | cv:C0265253 | |
| Disease | collagen disease (implicated_via_orthology) | 5.69e-09 | 12 | 56 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Stickler syndrome (disorder) | 6.47e-09 | 3 | 56 | 3 | C0265253 | |
| Disease | Disproportionate short stature | 7.58e-09 | 77 | 56 | 6 | C0878659 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.49e-08 | 53 | 56 | 5 | C4707243 | |
| Disease | Multiple Epiphyseal Dysplasia | 5.51e-08 | 20 | 56 | 4 | C0026760 | |
| Disease | Stickler syndrome, type 1 | 6.46e-08 | 5 | 56 | 3 | C2020284 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 6.46e-08 | 5 | 56 | 3 | cv:CN043640 | |
| Disease | Hereditary hearing loss and deafness | 3.50e-07 | 146 | 56 | 6 | cv:C0236038 | |
| Disease | Cleft Palate | 4.71e-07 | 81 | 56 | 5 | C0008925 | |
| Disease | Sensory hearing loss | 1.06e-06 | 11 | 56 | 3 | C1691779 | |
| Disease | Connective Tissue Diseases | 1.83e-06 | 13 | 56 | 3 | C0009782 | |
| Disease | myopathy (implicated_via_orthology) | 2.13e-06 | 48 | 56 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Disorder of eye | 3.08e-06 | 212 | 56 | 6 | C0015397 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 3.54e-06 | 2 | 56 | 2 | C1839884 | |
| Disease | Developmental Porencephaly | 3.54e-06 | 2 | 56 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 3.54e-06 | 2 | 56 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 3.54e-06 | 2 | 56 | 2 | C0302892 | |
| Disease | Megaepiphyseal dwarfism | 3.54e-06 | 2 | 56 | 2 | C1855310 | |
| Disease | Porencephaly | 3.54e-06 | 2 | 56 | 2 | C4082173 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 3.54e-06 | 2 | 56 | 2 | C4520892 | |
| Disease | PORENCEPHALY, FAMILIAL | 3.54e-06 | 2 | 56 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 3.54e-06 | 2 | 56 | 2 | C3281105 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 3.54e-06 | 2 | 56 | 2 | C4551998 | |
| Disease | Leiomyoma, Epithelioid | 3.54e-06 | 2 | 56 | 2 | C0086533 | |
| Disease | Stickler syndrome, type 3 | 3.54e-06 | 2 | 56 | 2 | C1861481 | |
| Disease | Alport syndrome (is_implicated_in) | 1.06e-05 | 3 | 56 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 1.06e-05 | 3 | 56 | 2 | cv:C3281105 | |
| Disease | Alport syndrome | 1.06e-05 | 3 | 56 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.06e-05 | 3 | 56 | 2 | cv:CN076135 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.06e-05 | 3 | 56 | 2 | 614519 | |
| Disease | Renal glomerular disease | 1.12e-05 | 23 | 56 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.12e-05 | 23 | 56 | 3 | C4521256 | |
| Disease | Sensorineural Hearing Loss (disorder) | 1.12e-05 | 23 | 56 | 3 | C0018784 | |
| Disease | Hematuria, Benign Familial | 2.12e-05 | 4 | 56 | 2 | C0241908 | |
| Disease | Alport Syndrome | 2.12e-05 | 4 | 56 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 3.52e-05 | 5 | 56 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 3.52e-05 | 5 | 56 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 3.52e-05 | 5 | 56 | 2 | C1567744 | |
| Disease | Cartilage Diseases | 5.28e-05 | 6 | 56 | 2 | C0007302 | |
| Disease | Chondromalacia | 5.28e-05 | 6 | 56 | 2 | C0085700 | |
| Disease | Intervertebral disc disorder | 5.28e-05 | 6 | 56 | 2 | C0158252 | |
| Disease | Early Pregnancy Loss | 5.58e-05 | 109 | 56 | 4 | C3830362 | |
| Disease | Miscarriage | 5.58e-05 | 109 | 56 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 5.58e-05 | 109 | 56 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 5.58e-05 | 109 | 56 | 4 | C0000822 | |
| Disease | Global developmental delay | 1.21e-04 | 133 | 56 | 4 | C0557874 | |
| Disease | Hematuria | 1.26e-04 | 9 | 56 | 2 | C0018965 | |
| Disease | obsolete aging | 1.88e-04 | 279 | 56 | 5 | GO_0007568 | |
| Disease | Microphthalmos | 1.92e-04 | 11 | 56 | 2 | C0026010 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 1.92e-04 | 11 | 56 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.28e-04 | 157 | 56 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.31e-04 | 12 | 56 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | cleft palate (is_implicated_in) | 2.31e-04 | 12 | 56 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Coffin-Siris syndrome | 2.72e-04 | 13 | 56 | 2 | C0265338 | |
| Disease | Spastic Paraplegia, Hereditary | 3.17e-04 | 14 | 56 | 2 | C0037773 | |
| Disease | osteoarthritis (implicated_via_orthology) | 3.66e-04 | 15 | 56 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Myopia | 3.66e-04 | 15 | 56 | 2 | C0027092 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.17e-04 | 16 | 56 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 4.17e-04 | 16 | 56 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 4.17e-04 | 16 | 56 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 4.17e-04 | 16 | 56 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.17e-04 | 16 | 56 | 2 | C3541456 | |
| Disease | waist-hip ratio | COL4A1 COL4A2 ZHX3 COL24A1 COL9A3 ZNF268 BARHL2 COL5A3 COL14A1 | 4.67e-04 | 1226 | 56 | 9 | EFO_0004343 |
| Disease | Van Buchem disease | 4.72e-04 | 17 | 56 | 2 | C0432272 | |
| Disease | Limb Deformities, Congenital | 4.72e-04 | 17 | 56 | 2 | C0206762 | |
| Disease | myocardial infarction | 5.31e-04 | 350 | 56 | 5 | EFO_0000612 | |
| Disease | Dyschondroplasias | 5.93e-04 | 19 | 56 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 5.93e-04 | 19 | 56 | 2 | C0029422 | |
| Disease | Pseudoaphakia | 9.51e-04 | 24 | 56 | 2 | C0524524 | |
| Disease | Lens Opacities | 9.51e-04 | 24 | 56 | 2 | C1510497 | |
| Disease | Nephrotic Syndrome | 1.20e-03 | 27 | 56 | 2 | C0027726 | |
| Disease | osteoarthritis (is_implicated_in) | 1.30e-03 | 28 | 56 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | Cerebral Hemorrhage | 1.30e-03 | 28 | 56 | 2 | C2937358 | |
| Disease | resistin measurement | 1.39e-03 | 29 | 56 | 2 | EFO_0004819 | |
| Disease | Age-related nuclear cataract | 1.59e-03 | 31 | 56 | 2 | HP_0011142 | |
| Disease | spontaneous coronary artery dissection | 1.59e-03 | 31 | 56 | 2 | EFO_0010820 | |
| Disease | coronary artery disease | 1.78e-03 | 1194 | 56 | 8 | EFO_0001645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFLGINGIPGHPGQP | 101 | Q14031 | |
| LPGLDGITGPQGAPG | 176 | Q14031 | |
| NPGLVGLKGSPGSPG | 871 | Q14031 | |
| PGLTGDPGAQGPVGL | 1391 | Q14031 | |
| GPLGLQGVPGVPGIT | 496 | Q14050 | |
| LVPTGKPGLGPGTGQ | 301 | O95196 | |
| GLPGTPGNTGPYGLV | 106 | Q01955 | |
| TGPLGPPGHGQTLGQ | 476 | P46379 | |
| PGLQGVPGNNGLPGQ | 921 | Q07092 | |
| VPGNNGLPGQPGLTA | 926 | Q07092 | |
| PGAVGSPGLPGLQGE | 1056 | Q07092 | |
| GPPDSQPLGTLGQGG | 31 | O15544 | |
| QGMPGIPGLSGIPGL | 1011 | P08572 | |
| VQGPPGLKGQTGFPG | 1141 | P08572 | |
| GLKGQTGFPGLTGPP | 1146 | P08572 | |
| LGTQQPPVAVPGGGG | 291 | Q8NFD5 | |
| LNVSLSVGQPPGPGG | 1181 | Q9HCU4 | |
| GNGPEILLGQGPPQQ | 416 | Q9NSY1 | |
| GPQGATGPLGPKGQT | 441 | P02458 | |
| TGPLGPKGQTGEPGI | 446 | P02458 | |
| GAQGLPGITGQSGLP | 846 | P02462 | |
| PGITGQSGLPGLPGQ | 851 | P02462 | |
| QSGLPGLPGQQGAPG | 856 | P02462 | |
| LPGPKGQQGVTGLVG | 1376 | P02462 | |
| GQQGVTGLVGIPGPP | 1381 | P02462 | |
| QLQGPFPAGSGLGVP | 756 | Q8IY17 | |
| AQPLQPPASVGGGGG | 31 | Q9H2S1 | |
| VTGLPNPGGGGGPQL | 236 | Q9H1B7 | |
| PAGGPQPGILGAVTG | 76 | P98177 | |
| GEPGLPGAVGQNGIP | 261 | Q9BXS0 | |
| PSTVGLLGPEGPGLG | 96 | Q7L5A3 | |
| QGTPGTQGLPGPQGA | 651 | P13942 | |
| TQGLPGPQGAIGPHG | 656 | P13942 | |
| TKGNQGPSGPQGPLG | 701 | P13942 | |
| GHPGLIGLIGPPGEQ | 1411 | P13942 | |
| LGPIGPSSPGLTLGG | 66 | Q86YD1 | |
| GPQGGPVLNTGHPLG | 31 | P0CG12 | |
| PPALPGSLGIQGPQG | 386 | Q14993 | |
| PGPPGIQGIHQTLGG | 426 | Q14993 | |
| IGIPGTPGVPGITGS | 1571 | Q05707 | |
| IQGVAGNPGQPGIPG | 636 | P29400 | |
| GQTITQPGKPGLPGN | 656 | P29400 | |
| GLQGQPGLPGPTGEK | 926 | P29400 | |
| GDPGISSIGLPGLPG | 1066 | P29400 | |
| AGPPGLIGEQGISGP | 2236 | P12111 | |
| QGITGPKGATGPPGI | 291 | Q14055 | |
| GGGLGTQPLPAQGPQ | 166 | O76076 | |
| QGIAGTPGVPGSPGI | 481 | Q96P44 | |
| GPVGPRGPQGLQGQQ | 216 | P05997 | |
| RGPQGLQGQQGGAGP | 221 | P05997 | |
| GLMGPQGLPGENGPV | 1426 | Q8NFW1 | |
| LIHGLGPGGQPALNP | 361 | Q9NY43 | |
| DAGLQGLPGVPGIPG | 566 | P20849 | |
| GLVGPQGSPGLPGQV | 2236 | Q02388 | |
| GLLGPQGQPGAAGIP | 2581 | Q02388 | |
| QQPPLVPTNSGGGGA | 121 | Q8NEL9 | |
| SQLPPGPSLGGLGLG | 171 | Q8NBF1 | |
| GQKPTGPGGPLIQNV | 306 | Q9UHL9 | |
| IPGLQGLPNGSPGGA | 211 | Q9NZM4 | |
| QNGGIPPIPGSLGSG | 1256 | Q9NSC2 | |
| PGTVPGPGALQGLGG | 206 | O75364 | |
| FQGQTGPPGPAGVLG | 906 | P25940 | |
| IGLPGQSGSEGPVGP | 1021 | P25940 | |
| SGGPGTQLPEGQQGP | 381 | Q96AC6 | |
| PGPGGLQSGQTIALP | 161 | Q96QR8 | |
| GLDGLGGPGVQLGSP | 21 | Q9Y3Y4 | |
| PQGGSQPGPSRGLSL | 1841 | Q5T011 | |
| ISGGNNPLGTPGTSP | 251 | O43765 | |
| GGVLGPAGLGPAQTP | 211 | Q9ULL5 | |
| APTGLQGPQGGLKPQ | 341 | Q9NZ20 | |
| GAPPGSLGPSEQIGQ | 1001 | Q8TAQ2 | |
| GISVPGKPGQQGPTG | 151 | Q03692 | |
| QTGLPGPEGIVGIPG | 1096 | Q17RW2 | |
| LVGGQLSGGLGLPPG | 341 | Q9H7S9 | |
| GQGTPGLQPLPGTPR | 36 | Q14587 | |
| PGLPPEQQALLGSGG | 386 | Q969Z4 | |
| GPGSQGIQGPVSQGP | 761 | Q9C0J8 | |
| GQPEGTGGGLLVTQP | 416 | Q9H4I2 | |
| GPVLQSGQGLPGVGI | 4176 | O14686 |